DR. REDDY'S LABORATORIES
Dr. Reddy's Laboratories Performance
52 Week Range
- Open Price
- Previous Close
Start SIP in DR. REDDY'S LABORATORIESStart SIP
Dr. Reddy's Laboratories Share Price
Dr. Reddy's Laboratories Investment Rating
Dr. Reddy's Laboratories has an operating revenue of Rs. 22,377.90 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around 0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 49 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
|Indicator||Sep 2022||Jun 2022||Mar 2022||Dec 2021||Sep 2021||Jun 2021||Mar 2021|
|Oper Rev Qtr Cr||4,866||3,616||3,632||3,480||3,823||3,434||3,351|
|Operating Expenses Qtr Cr||3,078||3,051||2,989||2,866||3,075||2,872||2,748|
|Operating Profit Qtr Cr||1,803||580||670||614||748||562||603|
|Depreciation Qtr Cr||226||222||205||205||207||197||211|
|Interest Qtr Cr||2||10||13||8||11||7||17|
|Tax Qtr Cr||577||252||147||123||200||131||145|
|Net Profit Qtr Cr||1,116||500||420||341||449||413||312|
Dr. Reddy's Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- Bearish Moving Average
- 20 Day
- 50 Day
- 100 Day
- 200 Day
- 20 Day
- 50 Day
- 100 Day
- 200 Day
Dr. Reddy's Laboratories Resistance and Support
|MACD Single Line||12.77|
Dr. Reddy's Laboratories Delivery and Volume
|Period||NSE + BSE Volume Avg||NSE + BSE Delivery Volume Avg||NSE + BSE Delivery Volume %|
Dr. Reddy's Laboratories Result Highlights
Dr. Reddy's Laboratories Synopsis
NSE-Medical-DiversifiedDr. Reddy's Labs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 14405.20 Cr. and Equity Capital is Rs. 83.20 Cr. for the Year ended 31/03/2022. Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507.
|Shares in Float||12.15|
|No of funds||740|
|U/D Vol ratio||1.1|
|LTDebt / Equity|
Dr. Reddy's Laboratories
|Foreign Portfolio Investors||26.26%||25.87%||25.16%|
|Financial Institutions/ Banks||0.02%||0.12%|
Dr. Reddy's Laboratories Management
|Mr. K Satish Reddy||Chairman|
|Mr. G V Prasad||Co-Chairman & Manag. Director|
|Mr. Leo Puri||Independent Director|
|Mr. Prasad R Menon||Independent Director|
|Ms. Shikha Sharma||Independent Director|
|Mr. Allan Oberman||Independent Director|
|Dr. Bruce L A Carter||Independent Director|
|Ms. Kalpana Morparia||Independent Director|
|Mr. Sridar Iyengar||Independent Director|
|Mr. Arun Madhavan Kumar||Independent Director|
Dr. Reddy's Laboratories Forecast
Dr. Reddy's Laboratories Corporate Action
|2022-05-19||Audited Results & Final Dividend|
Dr. Reddy's Laboratories FAQs
What is Share Price of Dr. Reddy's Laboratories ?
Dr. Reddy's Laboratories share price is ₹4474 As on 02 December, 2022 | 00:52
What is the Market Cap of Dr. Reddy's Laboratories ?
The Market Cap of Dr. Reddy's Laboratories is ₹74498 Cr As on 02 December, 2022 | 00:52
What is the P/E ratio of Dr. Reddy's Laboratories ?
The P/E ratio of Dr. Reddy's Laboratories is 23.9 As on 02 December, 2022 | 00:52
What is the PB ratio of Dr. Reddy's Laboratories ?
The PB ratio of Dr. Reddy's Laboratories is 3.9 As on 02 December, 2022 | 00:52
Q) How to buy Dr. Reddys Laboratories Ltd shares?
Ans - You can easily buy the shares of Dr. Reddys Laboratories Ltd, by registering at 5Paisa and by setting up a Demat Account in your name.
Q) What is the 52-week high and low price of shares of Dr Reddys Laboratories Ltd.
Ans – Dr Reddys Laboratories Ltd shares have a 52-week high of Rs 5,614.60 and a 52-week low of Rs 3,654.
Q) What is the Return of Equity on shares of Dr Reddys Laboratories Ltd for the past 1 year?
Ans – The Return on Equity on shares of Dr Reddys Laboratories Ltd is 11.8% for last year.
Q) What is the face value of a share of Dr Reddys Laboratories Ltd?
Ans – The face value of a share of Dr Reddys Laboratories Ltd. is INR 5 per share.
What is Dr Reddys Laboratories's stock price CAGR?
Dr Reddys Laboratories stock price CAGR for 10 Years stands at 12%, 5 Years at 8%, 3 Years at 20%, and 1 Year at -2%.
What is the ROE of Dr Reddys Laboratories?
The ROE of Dr Reddys Laboratories is 11%.
Is Dr Reddys Laboratories a good investment?
Dr Reddy's Laboratories has an operating revenue of Rs. 20,442.10 Cr. on a trailing 12-month basis. Annual revenue growth of 7% is good, Pre-tax margin of 15% is great. As per analysts rating in the last 6 months, the recommendation is to HOLD Dr Reddys Laboratories.
Who is the CEO of Dr Reddys Laboratories
Erez Israeli is the Chief Executive Officer (CEO) at Dr Reddy's Laboratories since 1 Aug 2019.
What is the Profit before tax of Dr. Reddys Laboratories Ltd stock?
Profit before tax of Dr. Reddys Laboratories Ltd stock for the quarter ended March 2022 is Rs 567 crores.